(+/-)-2-EXO-BROMO-3-ENDO-HYDROXY-7-ENDO-PHENYL-7-EXO-CHLOROBICYCLO-[3.2.0]-HEPT-6-ONE
Compound with spectra: 1 NMR
![(+/-)-2-EXO-BROMO-3-ENDO-HYDROXY-7-ENDO-PHENYL-7-EXO-CHLOROBICYCLO-[3.2.0]-HEPT-6-ONE](/api/compound/3eND4w35BoM.png?ph=true&h=300&w=458 "(+/-)-2-EXO-BROMO-3-ENDO-HYDROXY-7-ENDO-PHENYL-7-EXO-CHLOROBICYCLO-[3.2.0]-HEPT-6-ONE")
| SpectraBase Compound ID | 3eND4w35BoM |
|---|---|
| InChI | InChI=1S/C13H12BrClO2/c14-11-9(16)6-8-10(11)13(15,12(8)17)7-4-2-1-3-5-7/h1-5,8-11,16H,6H2/t8-,9+,10-,11-,13-/m0/s1 |
| InChIKey | SDBVAPKVPHIBHT-FBUUZDRASA-N |
| Mol Weight | 315.59 g/mol |
| Molecular Formula | C13H12BrClO2 |
| Exact Mass | 313.97092 g/mol |
| Enantiomer InChIKey | SDBVAPKVPHIBHT-UYNYGYNWSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Bicyclo[3.2.0]heptan-6-one, 2-bromo-3-hydroxy-7,7-diphenyl-
(1R,3R,6S,8S)-8-Methyl-8-phenyl-3-oxa-tricyclo[4.2.0.0*2,4*]octan-7-one
[PD-(2,9-DMPHEN)-CL2]
REL-1-BETA-(4,6-DIHYDROXY-2-METHOXY)-BENZOYL-REL-2-ALPHA-(2,6-DIMETHOXY-4-HYDROXY)-BENZOYL-REL-(3-BETA,4-ALPHA)-DIPHENYLCYCLOBUTANE
(2R,4R)-2-(bromomethyl)-4-ethyl-2-(naphthalen-2-yl)-4-phenylcyclopentan-1-one
1,1,3,3-TETRAETHYL-2,4,6-TRIMETHYLISOINDOLINE, HYDROBROMIDE
(2S,5S,1'R)-2-(tert-Butyl)-5-(1'-n-pentyl-3'-oxobutyl)-5-phenyl-1,3-dioxolan-4-one
4-Hydroxy-6-(2-methyl-4-dimethylamino-5-hydroxy-1-oxacyclohexyloxy)-7,16-diethyl-5,9,13,15-tetramethyl-1-oxacyclohexadeca-11,13-dien-2,10-dione
[1,1-D2]-2a-Methyl-2,2a,7,7a-tetrahydro-1H-cyclobut[a]inden-2-one
1-{[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanyl]methyl}-3,3-dimethyl-3,4-dihydroisoquinoline
| Title | Journal or Book | Year |
|---|---|---|
| Identification of novel mammalian squalene synthase inhibitors using a three-Dimensional pharmacophore | Bioorganic & Medicinal Chemistry | 2002 |